Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
Dual antiplatelet therapy (DAPT) is the mainstay of secondary prevention treatment for acute coronary syndrome (ACS) and ischemic stroke, especially after coronary intervention. DAPT consists of aspirin and P2Y12 receptor inhibitor (e.g. clopidogrel), and the use of DAPT has been increased over time...
Saved in:
Main Authors: | Muhammad Begawan Bestari, Ignatius R Joewono |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2019-11-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/1204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01) -
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01) -
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01) -
TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)